Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>microRNA-564 inhibits the aggressive phenotypes of papillary thyroid cancer by directly targeting astrocyte-elevated gene-1</p>
Zhenzhen Song, Huimei Yang, Xia Wu, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 4869-4881
Open Access | Times Cited: 17

Showing 17 citing articles:

Overexpression of METTL3 attenuates high-glucose induced RPE cell pyroptosis by regulating miR-25-3p/PTEN/Akt signaling cascade through DGCR8
Xu Zha, Xiaoting Xi, Xinyu Fan, et al.
Aging (2020) Vol. 12, Iss. 9, pp. 8137-8150
Open Access | Times Cited: 115
The role of microRNAs in the pathogenesis of thyroid cancer
Soudeh Ghafouri‐Fard, Zeinab Shirvani-Farsani, Mohammad Taheri
Non-coding RNA Research (2020) Vol. 5, Iss. 3, pp. 88-98
Open Access | Times Cited: 57
MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer
Amir Abbas Hamidi, Negin Taghehchian, Zahra Basirat, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 33
miR-564: A potential regulator of vascular smooth muscle cells and therapeutic target for aortic dissection
Min Li, Yanyan Yang, Jinbao Zong, et al.
Journal of Molecular and Cellular Cardiology (2022) Vol. 170, pp. 100-114
Closed Access | Times Cited: 25
MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment
Maria Papaioannou, Angeliki Chorti, Anthoula Chatzikyriakidou, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 20
MiR-1256 inhibits cell proliferation and cell cycle progression in papillary thyroid cancer by targeting 5-hydroxy tryptamine receptor 3A
Chaowen Wu, Liyuan Ma, Hongfa Wei, et al.
Human Cell (2020) Vol. 33, Iss. 3, pp. 630-640
Closed Access | Times Cited: 22
MicroRNA in Papillary Thyroid Carcinoma: A Systematic Review from 2018 to June 2020
Liviu Hîțu, Katalin Gábora, Eduard-Alexandru Bonci, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3118-3118
Open Access | Times Cited: 21
RETRACTED: KDM5B-mediated microRNA-448 up-regulation restrains papillary thyroid cancer cell progression and slows down tumor growth via TGIF1 repression
Ying Pu, Juan Xiang, Jiani Zhang
Life Sciences (2020) Vol. 250, pp. 117519-117519
Closed Access | Times Cited: 13
Global miRNA/proteomic analyses identify miRNAs at 14q32 and 3p21, which contribute to features of chronic iron-exposed fallopian tube epithelial cells
Ravneet Chhabra, Stephanie Rockfield, Jennifer Guergues, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 10
Upregulation of microRNA-143-3p induces apoptosis and suppresses proliferation, invasion, and migration of papillary thyroid carcinoma cells by targeting MSI2
Zhenglin Wang, Cong Wang, Wei Liu, et al.
Experimental and Molecular Pathology (2019) Vol. 112, pp. 104342-104342
Closed Access | Times Cited: 10
Silencing of circDPP4 suppresses cell progression of human prostate cancer and enhances docetaxel cytotoxicity through regulating the miR‐564/ZIC2 axis
Hao Gu, Zhongqi Duan
The Journal of Gene Medicine (2021) Vol. 24, Iss. 3
Closed Access | Times Cited: 8
MicroRNA‐203a‐3p may prevent the development of thyroid papillary carcinoma via repressing MAP3K1 and activating autophagy
Lei Dai, Weidong Zhang, Xianjiang Wu, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 6
Open Access | Times Cited: 6
LncRNA-ENST00000543604 exerts a tumor-promoting effect via miRNA 564/AEG-1 or ZNF326/EMT and predicts the prognosis of and chemotherapeutic effect in colorectal cancer
Weimin Wang, Zhen Zhou, Xiaojun Dai, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Modulatory role of miRNAs in thyroid and breast cancer progression and insights into their therapeutic manipulation
Rubai Ahmed, Sovan Samanta, Jhimli Banerjee, et al.
Current Research in Pharmacology and Drug Discovery (2022) Vol. 3, pp. 100131-100131
Open Access | Times Cited: 6
MicroRNA‑564 inhibits the progression of non‑small cell lung cancer via targeting plexin A4
Hui Ding, Liangpeng Li, Biao Gu, et al.
Experimental and Therapeutic Medicine (2021) Vol. 21, Iss. 4
Open Access | Times Cited: 4
Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer
Lina Liu, Yuhong Shi, Lai Qian, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 2
Noncoding way of the metastasis
Bakiye Göker Bağca, Alican Kuşoğlu, Selin Çeşmeli, et al.
Elsevier eBooks (2022), pp. 87-104
Closed Access
Page 1

Scroll to top